title: [Experience with combined therapy in lymphogranulomatosis].
abstract: The article gathers the experience of therapy for lymphogranulomatosis of 1122 patients during last 12 years, and gives the summary of its immediate results. The only radiation therapy was employed for 11.3% of patients, chemical therapy--for 1.2%, and combined therapy in which both radiation and chemical therapy were used--87%. The simultaneous employment of radiation and chemical therapy led to a considerable reduction of the period of treatment, moreover there were no pronounced depressions in medullary hemoplasty. The further progression of the disease was commonly marked only in the cases with general manifestation of illness and affection of more than two globate glands. It is recommended to continue polychemical treatment for a year after the patient's recovery in order to prevent relapses.
authors.forename: E V
authors.initials: EV
authors.lastname: Kizhaev
authors.forename: M S
authors.initials: MS
authors.lastname: Zav'ialov
mesh_terms: D003131:Combined Modality Therapy; D006689:Hodgkin Disease / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D006801:Humans; D009367:Neoplasm Staging; D012074:Remission Induction; D013997:Time Factors
vernacular_title: Opyt kombinirovannoĭ terapii limfogranulematoza.